The Unseen Struggle: A Biotech Breakthrough Hits an Unexpected Snag
A small biotech start-up's groundbreaking drug faces an unexpected approval delay from the FDA, highlighting broader regulatory challenges. The delayed drug aims to address a critical health issue affecting millions,…